Bicycle Therapeutics (BCYC) Other financing activities (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Other financing activities of $12000.0 for Q1 2026, down 63.64% on a QoQ basis from $33000.0 in Q4 2025, and up 500.0% year-over-year from $2000.0 in Q1 2025.
Bicycle Therapeutics (BCYC) Other financing activities (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Other financing activities history runs 9 years deep, the most recent figure standing at $12000.0 for Q1 2026.
- Quarterly Other financing activities rose 500.0% year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47000.0 (down 99.17% YoY) and the FY2025 annual result came in at $37000.0, down 99.51% from the prior year.
- Other financing activities was $12000.0 for Q1 2026 at Bicycle Therapeutics, down from $33000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $4.5 million in Q2 2024 and bottomed at $1000.0 in Q2 2025.
- A 5-year average of $544000.0 and a median of $165000.0 in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2024 — Other financing activities jumped 93450.0% — and 2025, when it tumbled 99.98%.
- Bicycle Therapeutics' Other financing activities stood at $185000.0 in 2022, then jumped by 103.24% to $376000.0 in 2023, then plunged by 34.84% to $245000.0 in 2024, then tumbled by 86.53% to $33000.0 in 2025, then slumped by 63.64% to $12000.0 in 2026.
- Business Quant data shows BCYC's Other financing activities at $12000.0 in Q1 2026, $33000.0 in Q4 2025, and $1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 245,000.00 |
| Dec 31, 2024 | 245,000.00 |
| Sep 30, 2024 | 912,000.00 |
| Sep 30, 2024 | 912,000.00 |
| Jun 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 376,000.00 |
| Dec 31, 2023 | 376,000.00 |